Literature DB >> 85413

The nature of mutation in Krabbe disease.

Y Ben-Yoseph, M Hungerford, H L Nadler.   

Abstract

Galactosylceramide beta-galactosidase cross reacting material was demonstrated in brain, liver, and skin fibroblasts from patients with Krabbe disease. The mutant enzyme was antigenically identical to the normal enzyme and exhibited similar electrophoretic mobility. Normal quantities of the catalytically deficient enzyme were measured in the patients' tissues by a sensitive single radial immunodiffusion assay, indicating that the mutation is in structural gene for the enzyme protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 85413      PMCID: PMC1685874     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

2.  Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease.

Authors:  D A Wenger; M Satter; J P Markey
Journal:  Biochem Biophys Res Commun       Date:  1973-07-17       Impact factor: 3.575

3.  A simple procedure for removal of Triton X-100 from protein samples.

Authors:  P W Holloway
Journal:  Anal Biochem       Date:  1973-05       Impact factor: 3.365

4.  Two immunologically distinct human acidic beta-galactosidase A isozymes.

Authors:  Y Ben-Yoseph; E Shapira; H L Nadler
Journal:  Enzyme       Date:  1977

5.  Specificities of the two genetically distinct beta-galactosidases in human sphingolipidoses.

Authors:  H Tanaka; K Suzuki
Journal:  Arch Biochem Biophys       Date:  1976-07       Impact factor: 4.013

Review 6.  Molecular genetics of GM1 beta-galactosidase.

Authors:  J S O'Brien
Journal:  Clin Genet       Date:  1975-11       Impact factor: 4.438

7.  Effect of bile salts on lactosylceramide beta-galactosidase activities in human brain, liver and cultured skin fibroblasts.

Authors:  M Sattler; C Clark
Journal:  Biochim Biophys Acta       Date:  1975-12-17

8.  Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

Authors:  K Suzuki; Y Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

9.  Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses.

Authors:  Y Ben-Yoseph; B K Burton; H L Nadler
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

10.  Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase.

Authors:  T Miyatake; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1972-08-07       Impact factor: 3.575

View more
  5 in total

1.  Demonstration of altered acidic hydrolases in fibroblasts from patients with mucolipidosis II by lectin titration.

Authors:  R Rousson; Y Ben-Yoseph; M B Fiddler; H L Nadler
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

2.  The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase.

Authors:  Y Ben-Yoseph; M Hungerford; H L Nadler
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

3.  Apparently normal extracellular acidic alpha-mannosidase in fibroblast cultures from patients with mannosidosis.

Authors:  Y Ben-Yoseph; C L DeFranco; J Charrow; L C Hahn; H L Nadler
Journal:  Am J Hum Genet       Date:  1982-01       Impact factor: 11.025

4.  Deficient phosphorylation of mannose residues of mannan in fibroblasts of patients with mucolipidoses II and III.

Authors:  Y Ben-Yoseph; L C Hahn; C L DeFranco; H L Nadler
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

5.  Self-association of human beta-galactocerebrosidase: Dependence on pH, salt, and surfactant.

Authors:  Eunhee Lee; Nazila Salamat-Miller; Walter F Stafford; Katherine Taylor
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.